Clinical Trial Update: A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of IV GSK2831781 in healthy volunteers and patients with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GSK2831781

Snippet

Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2019-08-16